Our viewpoint is that in cases of ultra rare diseases where there is no commercial model or opportunity for traditional forms of investment, access to gene therapies could be provided via a clinical ...
New breaches of personal data seem to occur daily. Still, many Canadians aren't yet ready to accept a world where others ...
C$2.6M Conditional Approval Extended to Advance Mont Royal’s Southern Road Access Strategy HIGHLIGHTS Mont Royal’s Managing Director, Nicholas Holthouse, said: “I would like to thank NRCan ...
This paper critically examines the Bui Dam hydroelectric project as a microcosm of the tensions inherent in China’s Belt and Road Initiative (BRI) and its impact on contemporary Sino-Ghanaian ...
C$2.6M Conditional Approval Extended to Advance Mont Royal's Southern Road Access Strategy HIGHLIGHTS Mont Royal's 100% owned subsidiary Commerce Resources has received an extension of conditional ...
CBSE Class 10 IT Exam 2026 will be conducted on 27th February 2026 from 10:30 AM to 12:30 PM. Check Top 50 Important MCQs ...
Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the fourth quarter and full-year 2025.
VR Resources Ltd. is pleased to announce that it has entered into a binding definitive agreement dated February 25, 2026 with Athos Metals Corp. , a private company, pursuant to which the Company has ...
Hyundai has turned to China to compete with the onslaught of Chinese electric SUVs. The Elexio drives well and is solid value ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results